Cutaneous Adverse Events in Pediatric Populations: Supplemental Table 1

Published: 16-11-2020| Version 1 | DOI: 10.17632/k4k4mxwrfp.1
Contributors:
Lindsay McCormack,
Leah Thompson,
Michael Chang,
Nicole Polyakov,
Hannah Song,
Steven Chen,
Jennifer Huang

Description

Characteristics of Pediatric Patients and Cutaneous Adverse Event (cAE) Features Among ICI Therapy Subgroups In this study, we characterized cAE features in a double-institutional pediatric cohort. While previous trials reported cAEs in three-percent of children, we observed cAEs in thirty-percent of our cohort, suggesting possible underdiagnosis. Clinical features of cAEs were similar to those reported in adults, with a high proportion of “maculopapular” reactions. The “maculopapular” descriptor may conflate different cAE subtypes, highlighting the need for enhanced clinical categorization. We observed infrequent treatment for cAEs, warranting further investigation.

Files